一个16周的渐进性运动训练干预在治疗先前的慢性淋巴细胞白血病:一个随机对照试点研究
Frankie F Brown1,2, Rebecca Oliver1,3, Rachel Eddy1
1Department for Health, University of Bath, Bath, United Kingdom.
Frontiers in oncology
|December 20, 2024
概括
这项试点研究发现,对于以前没有接受过治疗的慢性淋巴细胞白血病 (CLL) 患者来说,16周的运动计划是可行的和安全的,导致肌肉量增加. 进一步的研究是有必要的,以探索运动.
科学领域:
- * 血液学:专注于血液癌症,特别是慢性淋巴细胞白血病 (CLL).
背景情况:
- * 慢性淋巴细胞白血病 (CLL) 通常表现为无症状,早期疾病需要监测,直到进展.
- *这项研究研究了运动对未经治疗的CLL患者疾病活动的影响的潜力.
研究的目的:
- * 对以前未接受过治疗的CLL患者进行家庭运动计划的可行性和初步安全性进行评估.
- * 预先评估运动对该群体疾病活动和免疫细胞表型的影响.
主要方法:
- * 一项为期16周的随机对照试点研究,涉及28名以前未接受过治疗的CLL患者 (14例干预,14例对照).
- *干预:在家进行,部分监督,个性化,渐进的炼. 控制:通常的护理.
- *结果:安全性,可行性 (吸收,保留,坚持),疾病活性 (流动细胞计),身体成分 (DEXA),健康状况和心血管措施.
主要成果:
- *可行性:40%的吸收,86%的保留;92%的坚持运动.
- *安全性:一个无关的严重不良事件,一个相关的不良事件.
- * 身体构成:运动组的瘦肉量增加了2%,对照组的瘦肉量减少了0.4% (p=0.01). 其他身体成分,健康状况或心血管指标没有显著变化.
- * 疾病活性:在CLL细胞或T细胞子集中没有显著的组间差异.
结论:
- * 该炼计划对于接受过前期治疗的CLL患者来说是可行的和安全的.
- * 运动干预导致瘦肉量在统计学上显著增加.
- * 在这项试点研究中没有观察到对疾病活性或免疫细胞表型的显著影响.
相关概念视频
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


